During the past decade, CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie" #1 collaborator was "European Network of Gynaecological Oncological Trial Groups (ENGOT)" with 1 trials as a collaborator and "GOG Foundation" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie" are "Solid Tumors" (2 trials), "Advanced or Metastatic Esophageal Squamous Cell Carcinoma" (1 trials), "CNS Tumors" (1 trials), "Esophageal Squamous Cell Carcinoma" (1 trials) and "Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)" (1 trials). Many other conditions were trialed in "CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie" in a lesser frequency.

Most popular intervention types in "CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Entrectinib" (2 trials), "Inavolisib" (2 trials), "Ipatasertib" (2 trials) and "Abemaciclib" (1 trials). Other intervention names were less common.

The vast majority of trials in "CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie" are 7 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CENTRE LEON BERARD; Département d'Hématologie et d'Oncologie, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".